Dostarlimab: The miracle drug for the treatment of colorectal cancer

被引：1
|
作者：
Shuvo, Pollob Ahmed [1 ]
Tahsin, Anika [1 ]
Rahman, Md. Mominur [1 ]
Bin Emran, Talha [1 ,2 ]
机构：
[1] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Pharm, Dhaka 1207, Bangladesh
[2] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源：
ANNALS OF MEDICINE AND SURGERY | 2022年 / 81卷
关键词：
Cancer; Colorectal cancer; Dostarlimab; Programmed cell death; Tumors;
D O I：
10.1016/j.amsu.2022.104493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer
    Sadreddini, Sanam
    Safaralizadeh, Reza
    Baradaran, Behzad
    Aghebati-Maleki, Leili
    Hosseinpour-Feizi, Mohammad Ali
    Shanehbandi, Dariush
    Jadidi-Niaragh, Farhad
    Sadreddini, Sevil
    Kafil, Hossein Samadi
    Younesi, Vahid
    Yousefi, Mehdi
    IMMUNOLOGY LETTERS, 2017, 181 : 79 - 86
  • [42] TNK2 as a key drug target for the treatment of metastatic colorectal cancer
    Qi, Lu
    Ding, Yanqing
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 119 : 48 - 52
  • [43] Agomelatine, a Melatonin-Derived Drug, as a New Strategy for the Treatment of Colorectal Cancer
    Moreno-SanJuan, Sara
    Puentes-Pardo, Jose D.
    Casado, Jorge
    Escudero-Feliu, Julia
    Khaldy, Huda
    Arnedo, Javier
    Carazo, Angel
    Leon, Josefa
    ANTIOXIDANTS, 2023, 12 (04)
  • [44] Rationally designed treatment for metastatic colorectal cancer: Current drug development strategies
    Spiliopoulou, Pavlina
    Arkenau, Hendrik-Tobias
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (30) : 10288 - 10295
  • [45] Erratum to Treatment of colorectal cancer: current guidelines and future prospects for drug therapy
    R. Labianca
    M. A. Zamparelli
    Drugs, 1997, 54 : 160 - 160
  • [46] New drug regimen shows clear benefit in the treatment of advanced colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2002, 16 (09): : 1202 - 1202
  • [47] Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
    Zhu, Gui-Xian
    Gao, Dian
    Shao, Zhao-Zhao
    Chen, Li
    Ding, Wen-Jie
    Yu, Qiong-Fang
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
  • [48] A Novel Antitumor Drug-loaded Biodegradable Stent for the Treatment of Colorectal Cancer
    Li, Gang
    Li, Yi
    Lan, Ping
    Li, Jia-Shen
    Hu, Hong
    Wang, Wen-Zu
    Li, Yu-Ling
    Hu, Jun-Yan
    TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1-3, 2013, : 200 - 208
  • [49] An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
    Mathews, Cara
    Lorusso, Domenica
    Coleman, Robert L.
    Boklage, Susan
    Garside, Jamie
    ONCOLOGIST, 2022, 27 (12): : 1058 - 1066
  • [50] Miracle drug: Brazil approves never-tested cancer medicine
    Kuchenbecker, Ricardo S.
    Mota, Daniel M.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (05) : 399 - 400
12345